Neurodegenerative Disorder Therapeutics Market By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, and Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2029

Report Code: PMI437320 | Publish Date: March 2024 | No. of Pages: 168

Global Neurodegenerative Disorder Therapeutics Market Companies

  • Pfizer
  • Sanofi
  • Novartis
  • Teva Pharmaceutical
  • Hoffmann- La Roche, Ltd.
  • UCB, ACADIA Pharmaceuticals, Inc.
  • Lundeck A/S
  • Boehringer Ingeiheim International GmbH

Recent News:

  • According to Elsevier B.V. research article, Neurodegenerative disorders that threaten human society still lack disease-modifying medicines, even after a century of rigorous research. A well-established lack of resources and understanding has hampered the conversion of basic research into effective treatments.